Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
Amy K. Feehan, Daniel Fort, Julia Garcia‐Diaz, Eboni G. Price‐Haywood, Cruz Velasco, Eric Sapp, Dawn Pevey, Leonardo Seoane
Abstract
Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
Topics & Concepts
SeroprevalenceCase fatality rateSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCensusDemographyCoronavirus disease 2019 (COVID-19)PandemicVirologyGeographyImmunologyEnvironmental healthSerologyAntibodyInternal medicinePopulationInfectious disease (medical specialty)SociologyDiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies